Citalopram as adjunctive therapy in bipolar depression
Academic Article
Overview
MeSH Major
Antimanic Agents
Bipolar Disorder
Citalopram
abstract
The high response rate, the high rate of sustained remission, and the low rate of adverse events strongly support the use of citalopram as a treatment for bipolar I or II depression. These findings should stimulate a controlled double-blind trial to demonstrate even more clearly the usefulness of this drug in the therapeutic regimen for bipolar disorder.
